Abstract
Malaria remains one of the deadliest infectious diseases worldwide and continues to infect hundreds of millions of individuals each year. Here we report the discovery and derivatization of a series of 2,6-dibenzylidenecyclohexanones targeting the chloroquine-sensitive 3D7 strain of Plasmodium falciparum. While the initial lead compound displayed significant toxicity in a human cell proliferation assay, we were able to identify a derivative with no detectable toxicity and sub-micromolar potency.
| Original language | English (US) |
|---|---|
| Article number | 128216 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 47 |
| DOIs | |
| State | Published - Sep 1 2021 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2021 The Author(s)
Keywords
- 2,6-Dibenzylidenecyclohexanone
- Malaria
- Michael system
- Plasmodium falciparum
- Structure activity relationship